series-c-plus
Stage
2018
Founded
2
Investors
About
Octavebio develops a clinically validated blood test that measures multiple protein biomarkers to assess real-time disease activity in multiple sclerosis, aiding providers and patients in precision neurology care decisions.
Explore Octavebio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.